Literature DB >> 26282171

TIF1γ Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability.

Roxane M Pommier1, Johann Gout1, David F Vincent1, Lindsay B Alcaraz1, Nicolas Chuvin1, Vanessa Arfi1, Sylvie Martel1, Bastien Kaniewski1, Guillaume Devailly1, Geneviève Fourel1, Pascal Bernard2, Caroline Moyret-Lalle3, Stéphane Ansieau1, Alain Puisieux3, Ulrich Valcourt1, Stéphanie Sentis3, Laurent Bartholin4.   

Abstract

The transcription accessory factor TIF1γ/TRIM33/RFG7/PTC7/Ectodermin functions as a tumor suppressor that promotes development and cellular differentiation. However, its precise function in cancer has been elusive. In the present study, we report that TIF1γ inactivation causes cells to accumulate chromosomal defects, a hallmark of cancer, due to attenuations in the spindle assembly checkpoint and the post-mitotic checkpoint. TIF1γ deficiency also caused a loss of contact growth inhibition and increased anchorage-independent growth in vitro and in vivo. Clinically, reduced TIF1γ expression in human tumors correlated with an increased rate of genomic rearrangements. Overall, our work indicates that TIF1γ exerts its tumor-suppressive functions in part by promoting chromosomal stability. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26282171     DOI: 10.1158/0008-5472.CAN-14-3426

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Trim33 is required for appropriate development of pre-cardiogenic mesoderm.

Authors:  Sudha Rajderkar; Jeffrey M Mann; Christopher Panaretos; Kenji Yumoto; Hong-Dong Li; Yuji Mishina; Benjamin Ralston; Vesa Kaartinen
Journal:  Dev Biol       Date:  2019-03-30       Impact factor: 3.582

2.  Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis.

Authors:  Iago Pinal-Fernandez; Berta Ferrer-Fabregas; Ernesto Trallero-Araguas; Eva Balada; Maria Angeles Martínez; Jose César Milisenda; Gloria Aparicio-Español; Moises Labrador-Horrillo; Vicente Garcia-Patos; Josep M Grau-Junyent; Albert Selva-O'Callaghan
Journal:  Rheumatology (Oxford)       Date:  2018-02-01       Impact factor: 7.580

Review 3.  The cell cycle, cancer development and therapy.

Authors:  Elaheh Jamasbi; Mona Hamelian; Mohammed Akhter Hossain; Kambiz Varmira
Journal:  Mol Biol Rep       Date:  2022-08-05       Impact factor: 2.742

4.  SNX9 promotes metastasis by enhancing cancer cell invasion via differential regulation of RhoGTPases.

Authors:  Nawal Bendris; Karla C Williams; Carlos R Reis; Erik S Welf; Ping-Hung Chen; Bénédicte Lemmers; Michael Hahne; H S Leong; Sandra L Schmid
Journal:  Mol Biol Cell       Date:  2016-03-09       Impact factor: 4.138

Review 5.  Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer.

Authors:  Audrey Aussy; Olivier Boyer; Nadège Cordel
Journal:  Front Immunol       Date:  2017-08-21       Impact factor: 7.561

6.  TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.

Authors:  Yingkun Xu; Guangzhen Wu; Jiayao Zhang; Jianyi Li; Ningke Ruan; Jianfeng Zhang; Zhiyu Zhang; Yougen Chen; Qi Zhang; Qinghua Xia
Journal:  Biomed Res Int       Date:  2020-08-25       Impact factor: 3.411

7.  Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.

Authors:  Peng-Fei Zhang; Chuan-Yuan Wei; Xiao-Yong Huang; Rui Peng; Xuan Yang; Jia-Cheng Lu; Chi Zhang; Chao Gao; Jia-Bin Cai; Ping-Ting Gao; Dong-Mei Gao; Guo-Ming Shi; Ai-Wu Ke; Jia Fan
Journal:  Mol Cancer       Date:  2019-06-01       Impact factor: 27.401

Review 8.  The Roles of TIF1γ in Cancer.

Authors:  Chengpeng Yu; Zeyang Ding; Huifang Liang; Bixiang Zhang; Xiaoping Chen
Journal:  Front Oncol       Date:  2019-10-02       Impact factor: 6.244

9.  Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients.

Authors:  Sohei Kobayashi; Tyuji Hoshino; Takaki Hiwasa; Mamoru Satoh; Bahityar Rahmutulla; Sachio Tsuchida; Yuji Komukai; Tomoaki Tanaka; Hisahiro Matsubara; Hideaki Shimada; Fumio Nomura; Kazuyuki Matsushita
Journal:  Oncotarget       Date:  2016-12-13

Review 10.  TIF1 Proteins in Genome Stability and Cancer.

Authors:  Roisin M McAvera; Lisa J Crawford
Journal:  Cancers (Basel)       Date:  2020-07-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.